Multidrug resistance-associated protein 1 MSFFFKAIHD LMMFSGPQIL KLLIKFVNDT KAPDWQGYFY TVLLFVTACL QTLVLHQYFH ICFVSGMRIK TAVIGAVYRK ALVITNSARK SSTVGEIVNL MSVDAQRFMD LATYINMIWS APLQVILALY LLWLNLGPSV LAGVAVMVLM VPVNAVMAMK TKTYQVAHMK SKDNRIKLMN EILNGIKVLK LYAWELAFKD KVLAIRQEEL KVLKKSAYLS AVGTFTWVCT PFLVALCTFA VYVTIDENNI LDAQTAFVSL ALFNILRFPL NILPMVISSI VQASVSLKRL RIFLSHEELE PDSIERRPVK DGGGTNSITV RNATFTWARS DPPTLNGITF SIPEGALVAV VGQVGCGKSS LLSALLAEMD KVEGHVAIKG SVAYVPQQAW IQNDSLRENI LFGCQLEEPY YRSVIQACAL LPDLEILPSG DRTEIGEKGV NLSGGQKQRV SLARAVYSNA DIYLFDDPLS AVDAHVGKHI FENVIGPKGM LKNKTRILVT HSMSYLPQVD VIIVMSGGKI SEMGSYQELL ARDGAFAEFL RTYASTEQEQ DAEENGSTVM DEEEAGVTGV SGPGKEAKQM ENGMLVTDSA GKQLQRQLSS SSSYSGDISR HHNSTAELQK AEAKKEETWK LMEADKAQTG QVKLSVYWDY MKAIGLFISF LSIFLFMCNH VSALASNYWL SLWTDDPIVN GTQEHTKVRL SVYGALGISQ GIAVFGYSMA VSIGGILASR CLHVDLLHSI LRSPMSFFER TPSGNLVNRF SKELDTVDSM IPEVIKMFMG SLFNVIGACI VILLATPIAA IIIPPLGLIY FFVQRFYVAS SRQLKRLESV SRSPVYSHFN ETLLGVSVIR AFEEQERFIH QSDLKVDENQ KAYYPSIVAN RWLAVRLECV GNCIVLFAAL FAVISRHSLS AGLVGLSVSY SLQVTTYLNW LVRMSSEMET NIVAVERLKE YSETEKEAPW QIQETAPPSS WPQVGRVEFR NYCLRYREDL DFVLRHINVT INGGEKVGIV GRTGAGKSSL TLGLFRINES AEGEIIIDGI NIAKIGLHDL RFKITIIPQD PVLFSGSLRM NLDPFSQYSD EEVWTSLELA HLKDFVSALP DKLDHECAEG GENLSVGQRQ LVCLARALLR KTKILVLDEA TAAVDLETDD LIQSTIRTQF EDCTVLTIAH RLNTIMDYTR VIVLDKGEIQ EYGAPSDLLQ QRGLFYSMAK DAGLV